Epidemiological considerations for the use of databases in transfusion research: A Scandinavian perspective

Current Opinion in Hematology

Volumn 17, Issue 6, 2010, Pages 596-601

  Edgren, Gustaf ^a   Hjalgrim, Henrik ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

data mining; databases; donation; epidemiology; transfusion

Indexed keywords

BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; CANCER INCIDENCE; DATA BASE; DATA MINING; DISEASE TRANSMISSION; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; REVIEW; SCANDINAVIA;

BLOOD TRANSFUSION; DATABASES, FACTUAL; HUMANS; SCANDINAVIA;

EID: 77958556910     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833e73cf     Document Type: Review

References (37)

1. Stramer SL Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007; 131:702-707.
2. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood 2008; 112:2617-2626.
3. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334:1685-1690.
4. Freiesleben E, Jensen KG, Tamborg O. Registration of blood donors and electronic data processing [in Danish]. Ugeskr Laeger 1965; 127:1171-1176.
5. Hogman C. ADP and blood transfusion work [in Swedish]. Lakartidningen 1969; 66:125-128.
6. Hogman CF, Ramgren O. Computer system for blood transfusion service. Transfusion 1970; 10:121-132.
7. Singman D, Catassi CA, Smiley CR, et al. Computerized blood bank control. JAMA 1965; 194:583-586.
8. Edgren G, Hjalgrim H, Tran TN, et al. A population-based bi-national register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang 2006; 91:316-323.
9. Hogman CF, Cassemar B. A national blood transfusion system integrating a central computer service with hospital-based minicomputer routines. Vox Sang 1981; 40:222-227.
10. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24:659-667.
11. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53:441-449.
12. Blood Donor Suitability Workshop; 12 September 1999, Rockville, Maryland, USA. 1999. http://www.fda.gov/downloads/BiologicsBloodVaccines/News Events/WorkshopsMeetingsConferences/TranscriptsMinutes/UCM055440. pdf. [Accessed 16 July 2010]
13. Greenwald P, Woodard E, Nasca PC, et al. Morbidity and mortality among recipients of blood from preleukemic and prelymphomatous donors. Cancer 1976; 38:324-328.
14. Edgren G, Hjalgrim H, Reilly M, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet 2007; 369:1724-1730.
15. Edgren G,Tran TN, Hjalgrim H, et al. Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion 2007; 47:2017-2024.
16. Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst 2008; 100:572-579.
17. Edgren G, Bagnardi V, Bellocco R, et al. Pattern of declining hemoglobin concentration prior to cancer diagnosis. Int J Cancer 2010; 127:1429-1436.
18. Edgren G, Kamper-Jørgensen M, Eloranta S, et al. Duration of red blood cell concentrate storage and survival of transfused patients. Transfusion 2010; 50:1185-1195.
19. Hjalgrim H, Edgren G, Rostgaard K, et al. Cancer incidence in blood transfusion recipients. J Natl Cancer Inst 2007; 99:1864-1874.
20. Kamper-Jorgensen M, Ahlgren M, Rostgaard K, et al. Survival after blood transfusion. Transfusion 2008; 48:2577-2584.
21. Kamper-Jorgensen M, Edgren G, Rostgaard K, et al. Blood transfusion exposure in Denmark and Sweden. Transfusion 2009; 49:888-894.
22. Kamper-Jorgensen M, Hjalgrim H, Edgren G, et al. Expensive blood safety initiatives may offer less benefit than we think. Transfusion 2010; 50:240-242.
23. Shanwell A, Andersson TM, Rostgaard K, et al. Posttransfusion mortality among recipients of ABO-compatible but nonidentical plasma. Vox Sang 2009; 96:316-323.
24. Tynell E, Andersson TML, Norda R, et al. Should plasma from female donors be avoided? A population based cohort study of plasma recipients in Sweden 1990-2002. Transfusion 2010; 50:1249-1256.
25. Utter GH. The risk of transmitting cancer with transfusion. Lancet 2007; 369:1670-1671.
26. Titlestad K, Ahlgren M, Hjalgrim H, et al. Survival after blood transfusion: a study of more than one million transfusion recipients. Vox Sang 2006; 91 (Suppl 3):27.
27. Gajic O, Yilmaz M, Iscimen R, et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med 2007; 35:1645-1648.
28. Heal JM, Masel D, Rowe JM, Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993; 85:566-572.
29. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229-1239.
30. Van der Poel CL, Janssen MP, Borkent-Raven BA. The collection, testing, and use of blood and blood products in Europe in 2003.Strasbourg: Council of Europe; 2005.
31. Titlestad K, Kristensen T, Jorgensen J, Georgsen J. Monitoring transfusion practice: a computerized procedure. Transfus Med 2002; 12:25-34.
32. Palo R, Ali-Melkkila T, Hanhela R, et al. Development of permanent national register of blood component use utilizing electronic hospital information systems. Vox Sang 2006; 91:140-147.
33. Borkent-Raven BA, Janssen MP, van der Poel CL, et al. The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010; 99:54-64.
34. Stainsby D, Jones H, Asher D, et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006; 20:273-282.
35. Middelburg RA, Van de Watering LM, Van der Bom JG. Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research. Transfusion 2010;50:1181-1183.
36. Fomkin R, Stenbeck M, Litton JE. Federated databases as a basis for infrastructure supporting epidemiological research. In: Proceedings of the 2009 20th International Workshop on Database and Expert Systems Application; 2009. pp. 313-317.
37. Herasevich V, Pickering BW, Dong Y, et al. Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc 2010; 85:247-254.